Benzarone structure 
             | 
        Common Name | Benzarone | ||
|---|---|---|---|---|
| CAS Number | 1477-19-6 | Molecular Weight | 266.29100 | |
| Density | 1.234g/cm3 | Boiling Point | 473.6ºC at 760mmHg | |
| Molecular Formula | C17H14O3 | Melting Point | 124.3° | |
| MSDS | N/A | Flash Point | 240.2ºC | |
            Use of BenzaroneBenzarone (Fragivix) is a potent human uric acid transporter 1 (hURAT1) inhibitor, with an IC50 of 2.8 μM in oocyte. Benzarone could lower uric acid serum levels[1].  | 
    
| Name | (2-ethyl-1-benzofuran-3-yl)-(4-hydroxyphenyl)methanone | 
|---|---|
| Synonym | More Synonyms | 
| Description | Benzarone (Fragivix) is a potent human uric acid transporter 1 (hURAT1) inhibitor, with an IC50 of 2.8 μM in oocyte. Benzarone could lower uric acid serum levels[1]. | 
|---|---|
| Related Catalog | |
| Target | 
                                    
                                     IC50: 2.8 μM (hURAT1 in oocyte)[1]  | 
                            
| References | 
| Density | 1.234g/cm3 | 
|---|---|
| Boiling Point | 473.6ºC at 760mmHg | 
| Melting Point | 124.3° | 
| Molecular Formula | C17H14O3 | 
| Molecular Weight | 266.29100 | 
| Flash Point | 240.2ºC | 
| Exact Mass | 266.09400 | 
| PSA | 50.44000 | 
| LogP | 3.93180 | 
| Vapour Pressure | 1.36E-09mmHg at 25°C | 
| Index of Refraction | 1.638 | 
                                    CHEMICAL IDENTIFICATION
 
 
 
 
 
 
 
 
 HEALTH HAZARD DATAACUTE TOXICITY DATA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  | 
                            
| HS Code | 2932999099 | 
|---|
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~90%  
                                            Benzarone CAS#:1477-19-6  | 
                                
| Literature: J-PHARMA CO., LTD.; WEMPE, Michael, F.; ENDOU, Hitoshi Patent: WO2012/48058 A2, 2012 ; Location in patent: Page/Page column 14-15 ; WO 2012/048058 A2 | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            Benzarone CAS#:1477-19-6  | 
                                
| Literature: Bulletin de la Societe Chimique de France, , p. 1682,1685 | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            Benzarone CAS#:1477-19-6  | 
                                
| Literature: Journal of the Chemical Society, , p. 625,627 | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            Benzarone CAS#:1477-19-6  | 
                                
| Literature: Journal of Medicinal Chemistry, , vol. 54, # 8 p. 2701 - 2713 | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            Benzarone CAS#:1477-19-6  | 
                                
| Literature: Journal of Medicinal Chemistry, , vol. 54, # 8 p. 2701 - 2713 | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            Benzarone CAS#:1477-19-6  | 
                                
| Literature: WO2012/48058 A2, ; WO 2012/048058 A2 | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            Benzarone CAS#:1477-19-6  | 
                                
| Literature: Bulletin de la Societe Chimique de France, , p. 1682,1685 | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            Benzarone CAS#:1477-19-6  | 
                                
| Literature: Bulletin de la Societe Chimique de France, , p. 1682,1685 | 
| 
                                        
                                        
                                        
                                        
                                         ~%  
                                            Benzarone CAS#:1477-19-6  | 
                                
| Literature: Bulletin de la Societe Chimique de France, , p. 1682,1685 | 
| HS Code | 2932999099 | 
|---|---|
| Summary | 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% | 
| 
                                    
                                    Interactions of urate transporter URAT1 in human kidney with uricosuric drugs.
                                    
                                    
                                     Nephrology (Carlton.) 16(2) , 156-62, (2011) Hyperuricaemia is a significant factor in a variety of diseases, including gout and cardiovascular diseases. The kidney plays a dominant role in maintaining plasma urate levels through the excretion p...  | 
                                |
| 
                                    
                                    The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone.
                                    
                                    
                                     PLoS ONE 7(4) , e34806, (2012) Eyes Absents (EYA) are multifunctional proteins best known for their role in organogenesis. There is accumulating evidence that overexpression of EYAs in breast and ovarian cancers, and in malignant p...  | 
                                |
| 
                                    
                                    [Effect of benzarone on the oxygen consumption and the mechanical activity of vascular smooth muscle].
                                    
                                    
                                     Arzneimittelforschung 33(2) , 211-4, (1983) The influence of 2-ethyl-3-(4-hydroxy-benzoyl)-benzofurane (benzarone, Fragivic) on the energy metabolism of the wall of the rabbit common carotid artery and the rat portal vein was investigated by me...  | 
                                
| (2-Ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone | 
| Fragivix | 
| Benzarone | 
| (2-ETHYL-1-BENZOFURAN-3-YL)(4-HYDROXYPHENYL)METHANONE | 
| Fagivil | 
| Vasoc | 
| Fragivil | 
| Benzaron | 
| Venagil |